Evaluación electrofisiológica del tratamiento de pacientes con taquicardia ventricular recurrente.

Translated title of the contribution: Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia

I. Mendoza, F. Moleiro, Agustin Castellanos, H. Casal, E. Arends, V. Medina

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

In order to asses the predictive value of serial electrophysiologic studies in the selection of an effective long-term effective antiarrhythmic regimen, we studied 16 patients with recurrent sustained ventricular tachycardia (VT), resistant to conventional medical treatment. (group 1) Eleven patients in this group had chronic chagas myocarditis, and several hospitalizations and cardioversions had been required for therapy of VT. In addition, 35 patients (group 2: control) underwent electrophysiological studies to evaluate rhythm disturbances differences to TV. Ventricular Tachycardia was successfully initiated and terminate with programmed electrical stimulation of the right ventricle only in the group 1. After control studies, the effects of several drugs (ajmalin, amiodarone, carbamazepine, disopyramide, diphenilhydantoin, mexiletine, procainamide, propranolol, quinidine and verapamil on the ability to initiate VT were assessed. A drug was considered effective only if it prevented the initiation of VT and allowed long-term suppression o clinical VT. All the patients of group 1 were placed on chronic oral therapy with the effective agent and were followed for an average period of 16 months (range 5 to 47 months). In all 16 patients we could document complete long-term prophylaxis against VT. This method offers advantage in terms of morbidity, mortality, duration of therapy, and promptness of choosing an effective drug add expense to the patient over traditional empirical methods of drug selection.

Original languageSpanish
Pages (from-to)301-311
Number of pages11
JournalArchivos del Instituto de Cardiologia de Mexico
Volume52
Issue number4
StatePublished - Jul 1982
Externally publishedYes

Fingerprint

Ventricular Tachycardia
Pharmaceutical Preparations
Therapeutics
Chagas Cardiomyopathy
Mexiletine
Disopyramide
Procainamide
Electric Countershock
Amiodarone
Equidae
Carbamazepine
Propranolol
Electric Stimulation
Heart Ventricles
Hospitalization
Morbidity
Control Groups
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Mendoza, I., Moleiro, F., Castellanos, A., Casal, H., Arends, E., & Medina, V. (1982). Evaluación electrofisiológica del tratamiento de pacientes con taquicardia ventricular recurrente. Archivos del Instituto de Cardiologia de Mexico, 52(4), 301-311.

Evaluación electrofisiológica del tratamiento de pacientes con taquicardia ventricular recurrente. / Mendoza, I.; Moleiro, F.; Castellanos, Agustin; Casal, H.; Arends, E.; Medina, V.

In: Archivos del Instituto de Cardiologia de Mexico, Vol. 52, No. 4, 07.1982, p. 301-311.

Research output: Contribution to journalArticle

Mendoza, I, Moleiro, F, Castellanos, A, Casal, H, Arends, E & Medina, V 1982, 'Evaluación electrofisiológica del tratamiento de pacientes con taquicardia ventricular recurrente.', Archivos del Instituto de Cardiologia de Mexico, vol. 52, no. 4, pp. 301-311.
Mendoza, I. ; Moleiro, F. ; Castellanos, Agustin ; Casal, H. ; Arends, E. ; Medina, V. / Evaluación electrofisiológica del tratamiento de pacientes con taquicardia ventricular recurrente. In: Archivos del Instituto de Cardiologia de Mexico. 1982 ; Vol. 52, No. 4. pp. 301-311.
@article{5c7f757db34a49eb8b8782fbe9f72b3d,
title = "Evaluaci{\'o}n electrofisiol{\'o}gica del tratamiento de pacientes con taquicardia ventricular recurrente.",
abstract = "In order to asses the predictive value of serial electrophysiologic studies in the selection of an effective long-term effective antiarrhythmic regimen, we studied 16 patients with recurrent sustained ventricular tachycardia (VT), resistant to conventional medical treatment. (group 1) Eleven patients in this group had chronic chagas myocarditis, and several hospitalizations and cardioversions had been required for therapy of VT. In addition, 35 patients (group 2: control) underwent electrophysiological studies to evaluate rhythm disturbances differences to TV. Ventricular Tachycardia was successfully initiated and terminate with programmed electrical stimulation of the right ventricle only in the group 1. After control studies, the effects of several drugs (ajmalin, amiodarone, carbamazepine, disopyramide, diphenilhydantoin, mexiletine, procainamide, propranolol, quinidine and verapamil on the ability to initiate VT were assessed. A drug was considered effective only if it prevented the initiation of VT and allowed long-term suppression o clinical VT. All the patients of group 1 were placed on chronic oral therapy with the effective agent and were followed for an average period of 16 months (range 5 to 47 months). In all 16 patients we could document complete long-term prophylaxis against VT. This method offers advantage in terms of morbidity, mortality, duration of therapy, and promptness of choosing an effective drug add expense to the patient over traditional empirical methods of drug selection.",
author = "I. Mendoza and F. Moleiro and Agustin Castellanos and H. Casal and E. Arends and V. Medina",
year = "1982",
month = "7",
language = "Spanish",
volume = "52",
pages = "301--311",
journal = "Archivos de Cardiologia de Mexico",
issn = "1405-9940",
publisher = "Instituto Nacional de Cardiologia Ignazio Chavez",
number = "4",

}

TY - JOUR

T1 - Evaluación electrofisiológica del tratamiento de pacientes con taquicardia ventricular recurrente.

AU - Mendoza, I.

AU - Moleiro, F.

AU - Castellanos, Agustin

AU - Casal, H.

AU - Arends, E.

AU - Medina, V.

PY - 1982/7

Y1 - 1982/7

N2 - In order to asses the predictive value of serial electrophysiologic studies in the selection of an effective long-term effective antiarrhythmic regimen, we studied 16 patients with recurrent sustained ventricular tachycardia (VT), resistant to conventional medical treatment. (group 1) Eleven patients in this group had chronic chagas myocarditis, and several hospitalizations and cardioversions had been required for therapy of VT. In addition, 35 patients (group 2: control) underwent electrophysiological studies to evaluate rhythm disturbances differences to TV. Ventricular Tachycardia was successfully initiated and terminate with programmed electrical stimulation of the right ventricle only in the group 1. After control studies, the effects of several drugs (ajmalin, amiodarone, carbamazepine, disopyramide, diphenilhydantoin, mexiletine, procainamide, propranolol, quinidine and verapamil on the ability to initiate VT were assessed. A drug was considered effective only if it prevented the initiation of VT and allowed long-term suppression o clinical VT. All the patients of group 1 were placed on chronic oral therapy with the effective agent and were followed for an average period of 16 months (range 5 to 47 months). In all 16 patients we could document complete long-term prophylaxis against VT. This method offers advantage in terms of morbidity, mortality, duration of therapy, and promptness of choosing an effective drug add expense to the patient over traditional empirical methods of drug selection.

AB - In order to asses the predictive value of serial electrophysiologic studies in the selection of an effective long-term effective antiarrhythmic regimen, we studied 16 patients with recurrent sustained ventricular tachycardia (VT), resistant to conventional medical treatment. (group 1) Eleven patients in this group had chronic chagas myocarditis, and several hospitalizations and cardioversions had been required for therapy of VT. In addition, 35 patients (group 2: control) underwent electrophysiological studies to evaluate rhythm disturbances differences to TV. Ventricular Tachycardia was successfully initiated and terminate with programmed electrical stimulation of the right ventricle only in the group 1. After control studies, the effects of several drugs (ajmalin, amiodarone, carbamazepine, disopyramide, diphenilhydantoin, mexiletine, procainamide, propranolol, quinidine and verapamil on the ability to initiate VT were assessed. A drug was considered effective only if it prevented the initiation of VT and allowed long-term suppression o clinical VT. All the patients of group 1 were placed on chronic oral therapy with the effective agent and were followed for an average period of 16 months (range 5 to 47 months). In all 16 patients we could document complete long-term prophylaxis against VT. This method offers advantage in terms of morbidity, mortality, duration of therapy, and promptness of choosing an effective drug add expense to the patient over traditional empirical methods of drug selection.

UR - http://www.scopus.com/inward/record.url?scp=0020158534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020158534&partnerID=8YFLogxK

M3 - Article

VL - 52

SP - 301

EP - 311

JO - Archivos de Cardiologia de Mexico

JF - Archivos de Cardiologia de Mexico

SN - 1405-9940

IS - 4

ER -